We conducted additional analyses after stratifying the groups by age (≤40 or >40) and gender to determine whether age-specific or gender-specific variations influenced the association between the CXCL12 SNP genotypes and the MS incidence. This evidence concerns the gene CXCL12 and myeloid sarcoma.